Clinical Trial Update: Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial evaluated vitamin A palmitate supplementation in people with age-related macular degeneration (without reticular pseudodrusen) and delaye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Vitamin A Palmitate (retinyl palmitate)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: AMD | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-05-31